Cerebrospinal fluid (CSF) levels of Aβ1–42 (Aβ42), total Tau (tTau), and phosphorylated Tau181 (pTau181) are diagnostic markers of Alzheimer’s disease (AD)1,2. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.